Gennex Laboratories Ltd (NSE: GENNEX), ISIN INE509C01026 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GENNEX last traded at ₹8.87 (-1.33%), with a 52-week range of ₹7.05 to ₹17.25 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 23.62%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 67/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.